Healius Limited (AU:HLS) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Healius Limited has agreed to sell its imaging division, Lumus Imaging, to Affinity Equity Partners for $965 million, aiming to complete the deal by early 2025. The sale is part of a strategic restructuring to focus on core Pathology services and reduce debt, with anticipated net proceeds over $800 million earmarked for investment in their primary operations and returning cash to shareholders. This move is expected to significantly improve Healius’ financial position, enabling a leaner corporate structure and enhanced services.
For further insights into AU:HLS stock, check out TipRanks’ Stock Analysis page.
